Ethyl Acetate → HCID 10403166, Verbindung

HRID 1755630Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1755630
[Br:1]Br.[C:3]([N:7]1[C:13](=[O:14])[C:12]2[CH:15]=[CH:16][CH:17]=[CH:18][C:11]=2[NH:10][C:9](=[O:19])[CH2:8]1)([CH3:6])([CH3:5])[CH3:4].C([O-])(=O)C.[Na+].C(OCC)(=O)C>C(O)(=O)C>[Br:1][C:16]1[CH:17]=[CH:18][C:11]2[NH:10][C:9](=[O:19])[CH2:8][N:7]([C:3]([CH3:6])([CH3:4])[CH3:5])[C:13](=[O:14])[C:12]=2[CH:15]=1

Komponenten

6

Versuchsvorschrift

Bromine (1.72 g, 10.8 mmol) is added to a mixture of 4-tert-butyl-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione (1.0 g, 4.3 mmol) and sodium acetate (0.39 g, 4.8 mmol) in acetic acid. The reaction mixture is stirred at room temperature for 29 hours, concentrated in vacuo, diluted with ethyl acetate, washed sequentially with 0.1N sodium hydroxide solution and brine, dried over anhydrous sodium sulfate and concentrated in vacuo to give a residue. Chromatography of the residue using silica gel and 20% to 25% ethyl acetate in hexanes solutions gives the title product as a white solid (0.86 g, mp 205°-208° C.).

Aufarbeitung

  1. concentrationconcentrated in vacuo
  2. additiondiluted with ethyl acetate
  3. washwashed sequentially with 0.1N sodium hydroxide solution and brine
  4. dry with materialdried over anhydrous sodium sulfate
  5. concentrationconcentrated in vacuo
  6. customto give a residue

Quellen und Nachweise

ORD-Eintrag
ord-dab398a0f9f7430081f72a7e6c45e221
Quelldatensatz
uspto-grants-1995_08
Patentnummer
US05438035

Notizen zur Reaktion

Wird geladen…